Ignite Creation Date:
2024-05-05 @ 10:46 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01185626
Status:
COMPLETED
Last Update Posted:
2017-05-09
First Post:
2010-08-17
Brief Title:
ROGYcare The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
Sponsor:
Lonneke van de Poll-Franse
Organization:
Tilburg University
Study Overview
Official Title:
ROGYcare The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers A Pragmatic Cluster Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ROGYcare
Brief Summary:
Earlier diagnoses and improved treatments have contributed to the growing cohort of cancer survivors Nevertheless these patients remain at risk for adverse long-term or late physical or psychosocial effects of cancer and its treatment There is increasing recognition to improve information disclosure and cancer survivorship care The American Institute of Medicine IOM and Health Council of the Netherlands both recommend that cancer survivors receive a summary of their course of treatment as a formal document that also includes recommendations for subsequent cancer surveillance management of late effects and strategies for health promotion the Survivorship Care Plan SCP However no evidence exists concerning the positive and negative effects of the implementation of the SCP in daily clinical practice The purpose of this study is to assess the impact of SCP care in routine clinical practice on cancer survivors satisfaction with information disclosure and care quality of life illness perception and health care use
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None